Hereditary Hemorrhagic Telangiectasia Clinical Trials

60 clinical trials for Hereditary Hemorrhagic Telangiectasia across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia — RECRUITING · PHASE1
• Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT) — RECRUITING · PHASE1
• Comprehensive HHT Outcomes Registry of the United States (CHORUS) — RECRUITING
• Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia — RECRUITING · NA
• Topical TOR-582 Treatment of Epistaxis in HHT — RECRUITING · PHASE1
• Efficacy and Tolerance of Treatment With Bevacizumab for Severe Liver Involvement With High Cardiac Output in Hereditary Hemorrhagic Telangiectasia Within the French Hereditary Hemorrhagic Telangiectasia Network — RECRUITING
• Quality of Life in Patients With Hemorrhagic Telangiectasia — RECRUITING
• Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia — RECRUITING
• BEVACIZUMAB, AN ANTI-ANGIOGENIC MONOCLONAL ANTIBODY EFFECTIVE FOR PREVENTION OF HEMORRHAGING IN PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT): POSSIBLE REGRESSION OF VISCERAL ARTERIOVENOUS MALFORMATIONS — ACTIVE_NOT_RECRUITING · PHASE2
• Study to assess the efficacy clinical trial and safety of intranasal administration of ethamsylate in the treatment of hereditary hemorrhagic telangiectasia, during 4 weeks — COMPLETED · PHASE4
• A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT) — ACTIVE_NOT_RECRUITING · PHASE1
• A Trial to Assess the Efficacy and Safety of Engasertib in Participants With Moderate to Severe Hereditary Hemorrhagic Telangiectasia (HHT) — NOT_YET_RECRUITING · PHASE3
• Pomalidomide for the Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia Longitudinal Assessment Study — COMPLETED
• InsigHHT: A Phase 1/2, Randomized, Double-blind, Placebo-controlled, 2 part Study of the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Dose ALN-6400 in Adult Healthy Volunteers and Multiple Dose ALN 6400 in Adult Patients with Hereditary Hemorrhagic Telangiectasia (HHT) — TERMINATED · PHASE2
• Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients — TERMINATED · PHASE3
• Sirolimus for Nosebleeds in HHT — COMPLETED · PHASE2
• Bevacizumab In Hereditary Hemorrhagic Telangiectasia — ACTIVE_NOT_RECRUITING · PHASE2
• Ultra-low-dose Chest CT for HHT — COMPLETED
• Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia — COMPLETED
• CHORUS - Comprehensive HHT Outcomes Registry of the United States (Formerly OUR HHT Registry) — ACTIVE_NOT_RECRUITING
• A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia — WITHDRAWN · PHASE1
• Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) — ACTIVE_NOT_RECRUITING · PHASE2
• Assess Safety and Efficacy of VAD044 in HHT Patients — ACTIVE_NOT_RECRUITING · PHASE1
• Stress-Echography in Hereditary Haemorrhagic Telangiectasia Patient With Hepatic Involvement — COMPLETED · NA
• Description of the Impact of Symptoms on Quality of Life in HHT Disease: DISQUO — COMPLETED
• Cardiac Evaluation in Hereditary Hemorrhagic Telangiectasia — NOT_YET_RECRUITING
• Doxycycline for Hereditary Hemorrhagic Telangiectasia — COMPLETED · PHASE2
• Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT) — COMPLETED · PHASE2
• Genotype-phenotype Association in Hereditary Hemorrhagic Telangiectasia — COMPLETED
• At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions — COMPLETED
• Frequency of Common Medical Conditions in People With and Without HHT — COMPLETED · NA
• Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs — COMPLETED · NA
• Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept — COMPLETED · PHASE1
• Counseling Intervention in Hereditary Hemorrhagic Telangiectasia in the COVID Era. — COMPLETED · NA
• Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia — OTHER · PHASE1
• Nationwide Awareness Campaign and Call for Dental Screening for HHT in Germany — OTHER
• Intranasal Bevacizumab for HHT-Related Epistaxis — COMPLETED · PHASE4
• Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia — COMPLETED · PHASE2
• Development of a Quality of Life Measurement Scale in Hereditary Haemorrhagic Telangiectasia (HHT) Disease. — COMPLETED
• Prospective Descriptive Study of the Angiogenic T Cell Population in Subjects With Hereditary Hemorrhagic Telangiectasia (HHT) — COMPLETED
• Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study — COMPLETED · PHASE1
• Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT) — COMPLETED · NA
• Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) — COMPLETED · PHASE2
• Graded TTCE for Post-Embolization PAVM Monitoring — COMPLETED
• Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia — COMPLETED · PHASE1
• Evaluation of Obstetrical and Neonatal Complications in Hereditary Haemorrhagic Telangiectasia (HHT) — COMPLETED
• Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) — COMPLETED · PHASE2
• MRA With Feraheme in HHT — COMPLETED · PHASE1
• Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber — OTHER · PHASE2
• Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia — COMPLETED · PHASE2

Refine this search